Zacks Investment Research downgraded shares of HealthStream (NASDAQ:HSTM) from a hold rating to a sell rating in a research report sent to investors on Wednesday, January 3rd.
According to Zacks, “HealthStream is dedicated to improving patient outcomes through the development of healthcare organizations’ greatest asset: their people. Their unified suite of solutions is contracted by, collectively, over 4.5 million healthcare employees in the U.S. for workforce development, training & learning management, talent management, performance assessment, and managing simulation-based education programs. Their research solutions provide valuable insight to healthcare providers to meet HCAHPS requirements, improve the patient experience, engage their workforce, and enhance physician alignment. Their provider solutions offer healthcare providers innovative tools to support healthcare organizations in appropriately credentialing and privileging their workforce. “
A number of other research analysts have also commented on the company. Needham & Company LLC reaffirmed a hold rating and set a $26.00 price target on shares of HealthStream in a research report on Tuesday, October 24th. Canaccord Genuity reissued a hold rating and issued a $25.00 target price on shares of HealthStream in a research report on Monday, October 23rd. Robert W. Baird reduced their price objective on HealthStream from $30.00 to $28.00 and set an outperform rating for the company in a research report on Wednesday, October 25th. Finally, ValuEngine raised HealthStream from a sell rating to a hold rating in a research report on Wednesday, January 3rd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of Hold and a consensus target price of $24.83.
HealthStream (NASDAQ HSTM) traded up $0.97 during trading hours on Wednesday, hitting $24.40. The company had a trading volume of 119,900 shares, compared to its average volume of 88,912. The company has a market cap of $751.16, a price-to-earnings ratio of 135.56, a price-to-earnings-growth ratio of 4.99 and a beta of 0.91. HealthStream has a 12 month low of $20.60 and a 12 month high of $31.53.
HealthStream (NASDAQ:HSTM) last posted its quarterly earnings data on Monday, October 23rd. The technology company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03. The firm had revenue of $63.60 million during the quarter, compared to analysts’ expectations of $62.48 million. HealthStream had a return on equity of 2.46% and a net margin of 2.36%. The company’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.04 EPS. equities analysts forecast that HealthStream will post 0.23 EPS for the current fiscal year.
Several hedge funds have recently added to or reduced their stakes in the company. Stevens Capital Management LP purchased a new position in HealthStream during the third quarter valued at $367,000. FMR LLC lifted its position in HealthStream by 2.5% during the second quarter. FMR LLC now owns 4,733,510 shares of the technology company’s stock valued at $124,586,000 after purchasing an additional 116,309 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in HealthStream by 65.6% during the third quarter. BNP Paribas Arbitrage SA now owns 13,466 shares of the technology company’s stock valued at $315,000 after purchasing an additional 5,335 shares in the last quarter. Algert Global LLC bought a new stake in HealthStream during the third quarter valued at about $1,948,000. Finally, Northern Trust Corp raised its holdings in HealthStream by 6.1% during the second quarter. Northern Trust Corp now owns 468,703 shares of the technology company’s stock valued at $12,337,000 after acquiring an additional 27,080 shares during the period. Hedge funds and other institutional investors own 74.32% of the company’s stock.
TRADEMARK VIOLATION WARNING: “HealthStream (HSTM) Stock Rating Lowered by Zacks Investment Research” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/01/12/healthstream-hstm-rating-lowered-to-sell-at-zacks-investment-research.html.
HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.
Get a free copy of the Zacks research report on HealthStream (HSTM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.